# Efficacy of Isradipine in Early Parkinson Disease

> **NCT02168842** · PHASE3 · COMPLETED · sponsor: **University of Rochester** · enrollment: 336 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Isradipine
- **DRUG:** Placebo (for Isradipine)

## Key facts

- **NCT ID:** NCT02168842
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168842, "Efficacy of Isradipine in Early Parkinson Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02168842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*